Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation
Effect of Terlipressin for Intraoperative Blood Pressure Management in Kidney Transplantation, a Double-blind Randomized Controlled Trial
Beijing Friendship Hospital
150 participants
Mar 6, 2025
INTERVENTIONAL
Conditions
Summary
Prospective double blind randomized controlled trial. By randomizing patients undergoing kidney transplantation into a conventional catecholamine drug (dobutamine) blood pressure maintenance group and a terlipressin-complexed dobutamine group, the investigators compared the effect of intraoperative blood pressure maintenance and the dosage of the vasoactive drug, postoperative graft function, delayed graft function, and other related complications between the two groups, in order to demonstrate whether the use of terlipressin for blood pressure regulation during kidney transplantation is superior to the existing treatments.
Eligibility
Inclusion Criteria1
- Patients with end-stage renal disease aged 18 years or above
Exclusion Criteria6
- simultaneous multiple organ transplantation
- known allergy to study medication
- known pregnancy status
- cancellation of surgery due to grafts or personal reasons
- persistent severe preoperative hypertension that may not require intraoperative supportive therapy with vasoactive medications
- any other reason that the supervising physician or the anesthesiologist on duty think the patient is not suitable for the study
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Terlipressin was given prior to the opening of the graft circulation (with the possibility of reperfusion hypotension) when the blood pressure is suboptimal and does not respond well to dobutamine or fluid volume resuscitation. 1 mg terlipressin + 100 ml of sodium chloride injections was given for intravenous infusion.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06855758